Zilovertamab vedotin
Merck,Oncternal Therapeutics
['lymphoma', 'dlbcl', 'lymsm', ' vedo', 'zilovertamab']
muhit zcan, md, on dlbcl: early results on zilovertamab vedotin #lymsm #lymphoma #hematology #asco23 
News and views from the world of clinical oncology and hematology